Orient Europharma Co (ROCO:4120) Ending Cash Position : NT$1,435 Mil (As of Dec. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Orient Europharma Co Ending Cash Position?

Orient Europharma Co's Ending Cash Position for the quarter that ended in Dec. 2024 was NT$1,435 Mil.

Orient Europharma Co's quarterly Ending Cash Position increased from Jun. 2024 (NT$1,397 Mil) to Sep. 2024 (NT$1,456 Mil) but then declined from Sep. 2024 (NT$1,456 Mil) to Dec. 2024 (NT$1,435 Mil).

Orient Europharma Co's annual Ending Cash Position declined from Dec. 2022 (NT$1,801 Mil) to Dec. 2023 (NT$1,736 Mil) and declined from Dec. 2023 (NT$1,736 Mil) to Dec. 2024 (NT$1,435 Mil).

Orient Europharma Co Ending Cash Position Historical Data

The historical data trend for Orient Europharma Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orient Europharma Co Ending Cash Position Chart

Orient Europharma Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

2,121.39

1,959.30

1,801.02

1,736.12

1,435.09

Orient Europharma Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															1,736.12	1,558.83	1,397.11	1,455.71	1,435.09

Orient Europharma Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Orient Europharma Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1736.116	+	-301.028
	=	1,435

Orient Europharma Co's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1455.712	+	-20.624
	=	1,435

Orient Europharma Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Orient Europharma Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Orient Europharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orient Europharma Co Ltd (ROCO:4120) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

13th Floor, No. 128, Chengde Rd., Section 6, Beitou Distrit, Taipei, TWN, 112052

Website

https://www.oepgroup.com

Orient Europharma Co Ltd is a Taiwan-based company engaged in the wholesale of Western Pharmaceutical and Medical Devices. The firm also manufactures drugs and medicines, Beverages, Cleaning Preparations, Cosmetics, Medical Devices, and Other Food Products. Its products cover various therapeutic areas, including the central nervous system, cardiovascular, diabetes, allergy, cosmetics, and health supplements.

Orient Europharma Co Headlines

No Headlines